ArticleCPT: pharmacometrics & systems pharmacology2022

Pharmacokinetic-pharmacodynamic modelling of the anti-FcRn monoclonal antibody rozanolixizumab: Translation from preclinical stages to the clinic.

Rocio Lledo-Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.